While BRCA1 and CCDC98 are downregulated in ovarian cancer, RAP80, MERIT40 and BRCC45 are slightly amplified in ovarian cancer, but not comparable to USP13 amplification (Fig. 6a and Supplementary Fig. 9a). This evidence concerns the gene BABAM2 and ovarian carcinoma.